Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines

被引:457
作者
Hilgendorf, Constanze
Ahlin, Gustav
Seithel, Annick
Artursson, Per
Ungell, Anna-Lena
Karlsson, Johan
机构
[1] Astra Zeneca R&D Molndal, Discovery DMPK & Bioanalyt Chem, S-43183 Molndal, Sweden
[2] Uppsala Univ, Dept Pharm, Uppsala, Sweden
关键词
D O I
10.1124/dmd.107.014902
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study was designed to quantitatively assess the mRNA expression of 36 important drug transporters in human jejunum, colon, liver, and kidney. Expression of these transporters in human organs was compared with expression in commonly used cell lines (Caco-2, HepG2, and Caki-1) originating from these organs to assess their value as in vitro transporter system models, and was also compared with data obtained from the literature on expression in rat tissues to assess species differences. Transporters that were highly expressed in the intestine included HPT1, PEPT1, BCRP, MRP2, and MDR1, whereas, in the liver, OCT1, MRP2, OATP-C, NTCP and BSEP were the main transporters. In the kidney, OAT1 was expressed at the highest levels, followed by OAT3, OAT4, MCT5, MDR1, MRP2, OCT2, and OCTN2. The best agreement between human tissue and the representative cell line was observed for human jejunum and Caco-2 cells. Expression in liver and kidney ortholog cell lines was not correlated with that in the associated tissue. Comparisons with rat transporter gene expression revealed significant species differences. Our results allowed a comprehensive quantitative comparison of drug transporter expression in human intestine, liver, and kidney. We suggest that it would be beneficial for predictive pharmacokinetic research to focus on the most highly expressed transporters. We hope that our comparison of rat and human tissue will help to explain the observed species differences in in vivo models, increase understanding of the impact of active transport processes on pharmacokinetics and distribution, and improve the quality of predictions from animal studies to humans.
引用
收藏
页码:1333 / 1340
页数:8
相关论文
共 41 条
[1]   Messenger RNA expression of transporter and ion channel genes in undifferentiated and differentiated Caco-2 cells compared to human intestines [J].
Anderle, P ;
Rakhmanova, V ;
Woodford, K ;
Zerangue, N ;
Sadée, W .
PHARMACEUTICAL RESEARCH, 2003, 20 (01) :3-15
[2]  
*APPL BIOS, 1997, REL QUANT GEN EXPR U, V2
[3]   Xenobiotic and endobiotic transporter mRNA expression in the blood-testis barrier [J].
Augustine, LM ;
Markelewicz, RJ ;
Boekelheide, K ;
Cherrington, NJ .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (01) :182-189
[4]   Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1) [J].
Bakos, Eva ;
Homolya, Laszlo .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2007, 453 (05) :621-641
[5]   Variation of peptide transporter (PepT1 expression in Caco-2 cells as a function and HPT1) of cell origin [J].
Behrens, I ;
Kamm, W ;
Dantzig, AH ;
Kissel, T .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (07) :1743-1754
[6]   Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: A resource for investigations into drug disposition [J].
Bleasby, K. ;
Castle, J. C. ;
Roberts, C. J. ;
Cheng, C. ;
Bailey, W. J. ;
Sina, J. F. ;
Kulkarni, A. V. ;
Hafey, M. J. ;
Evers, R. ;
Johnson, J. M. ;
Ulrich, R. G. ;
Slatter, J. G. .
XENOBIOTICA, 2006, 36 (10-11) :963-988
[7]   Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2 [J].
Cui, YH ;
König, J ;
Keppler, D .
MOLECULAR PHARMACOLOGY, 2001, 60 (05) :934-943
[8]   XP13512 [(±)-1-([(α-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug:: II.: Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys [J].
Cundy, KC ;
Annamalai, T ;
Bu, L ;
De Vera, J ;
Estrela, J ;
Luo, W ;
Shirsat, P ;
Torneros, A ;
Yao, FM ;
Zou, J ;
Barrett, RW ;
Gallop, MA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (01) :324-333
[9]  
DELANGE EC, 2004, ADV DRUG DELIV REV, V56, P1809
[10]   ABC of oral bioavailability: transporters as gatekeepers in the gut [J].
Dietrich, CG ;
Geier, A ;
Elferink, RPJO .
GUT, 2003, 52 (12) :1788-1795